Skip to content

Life Quality Study for PFAPA Patient

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02811705
Acronym
PFAPA
Enrollment
60
Registered
2016-06-23
Start date
2015-07-31
Completion date
2017-04-30
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PFAPA Syndrome

Brief summary

This cohort study aims to assess the quality of life (or welfare) related to the health of children and adolescents with an non genetics auto-inflammatory disease PFAPA or Marshall syndrome to compare it to children or adolescents with recurrent fever genetics of Familial Mediterranean fever (FMF) in order to improve their overall care.

Interventions

OTHERQuality of life

Quality of life

Sponsors

Versailles Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* PFAPA syndrome patients or FMF patients

Exclusion criteria

* Participation refusal

Design outcomes

Primary

MeasureTime frame
Compare quality of life from patients with PFAPA and FMF, reported by parents and by patients themselves1 day

Secondary

MeasureTime frame
Evaluate the fatigue status of patients through questionnaire PedsQL TM 3.0 multidimensional scale tiredness1 day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026